Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - KAPOOR JOHN N
Last Updated 
30-May-16
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

KAPOOR JOHN N: Declared Holdings
Company/RelationshipReportedShares  Ownership
Akorn, Inc.
Director
NasdaqGS:AKRX
(historical quotes, profile, other insiders)
11-Dec-1530,946,075  Indirect
Insys Therapeutics, Inc.
Director
NasdaqGM:INSY
(historical quotes, profile, other insiders)
16-Jun-1421,202,949  Indirect

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
11-Dec-15 *15,050,000AKRX Acquisition (Non Open Market) at $0 per share.
11-Dec-15 *15,050,000AKRX Disposition (Non Open Market) at $0 per share.
10-Mar-15 *19,000AKRX Purchase at $44.26 - $44.26 per share.
(Cost of about $841,000)
11-Dec-14 *32,300AKRX Sale at $41.17 - $41.17 per share.
(Proceeds of about $1,330,000)
10-Dec-14 *17,700AKRX Sale at $41.22 - $41.22 per share.
(Proceeds of about $730,000)
26-Aug-14 *50,000AKRX Sale at $38.99 - $38.99 per share.
(Proceeds of about $1,950,000)
16-Jun-14 *5,000INSY Purchase at $25.85 - $26.53 per share.
(Cost of about $131,000)
13-Jun-14 *5,000INSY Purchase at $24.56 - $25.98 per share.
(Cost of about $126,000)
12-Jun-14 *20,000INSY Purchase at $24.84 - $24.84 per share.
(Cost of about $497,000)
11-Jun-14 *20,000INSY Purchase at $24.54 - $24.54 per share.
(Cost of about $491,000)
    * Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)



EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?